Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Deloitte
Cantor Fitzgerald
US Department of Justice
Merck
Healthtrust
AstraZeneca
Colorcon
Cerilliant
US Army

Generated: February 25, 2018

DrugPatentWatch Database Preview

Spirapril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for spirapril hydrochloride and what is the scope of spirapril hydrochloride patent protection?

Spirapril hydrochloride
is the generic ingredient in one branded drug marketed by Schering and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for spirapril hydrochloride

US Patents and Regulatory Information for spirapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-003 Dec 29, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-004 Dec 29, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-002 Dec 29, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-001 Dec 29, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for spirapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-001 Dec 29, 1994 ➤ Sign Up ➤ Sign Up
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-004 Dec 29, 1994 ➤ Sign Up ➤ Sign Up
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-002 Dec 29, 1994 ➤ Sign Up ➤ Sign Up
Schering RENORMAX spirapril hydrochloride TABLET;ORAL 020240-003 Dec 29, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
Cerilliant
AstraZeneca
Moodys
Fuji
US Army
Farmers Insurance
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot